Tasso & InnoVero to Supply Anti-Doping Test to 2024 Paris Olympics, Expanded Partnership

What You Should Know:

– InnoVero, a global leader in providing innovative, athlete-centric collection technologies to anti-doping organizations worldwide and Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, today announced the extension of their partnership that was first initiated in 2021.

– In addition to collaboratively developing new athlete-centric solutions, InnoVero will continue to serve as the exclusive worldwide distributor of Tasso blood collection solutions for the anti-doping marketplace.

Revolutionizing Anti-Doping: InnoVero and Tasso’s SAFESystem™ for Secure, Painless Blood Testing

As part of the InnoVero SAFESystem™ product suite, a secure, intuitive, and virtually painless system for anti-doping blood testing has been co-developed. This system leverages Tasso’s signature capillary blood collection technology, eliminating the need for traditional venipuncture or fingerstick collections. This innovative solution has been well-received by athletes, doping control officers, administrators, and laboratories, and is increasingly utilized in anti-doping programs worldwide. Professional and Olympic sports organizations, including those for the upcoming Paris 2024 Olympic Games, have quickly adopted this athlete-centric technology.

InnoVero delivers innovation and integrity to the global anti-doping community with solutions that secure global athlete trust. The SAFESystem™ sample collection solutions, featuring advanced security mechanisms, ensure that sample collection bottles are secure, athlete-friendly, and tamper-evident. These features provide seamless and efficient use for athletes, doping control officers, and laboratories, serving clients globally.

“Our partnership with Tasso is helping us deliver on our promise to drive innovation and integrity in anti-doping products. Tasso’s signature capillary blood collection technology has significantly improved the blood collection process providing an efficient, easy-to-implement, and athletic-centric solution” said Gabe Baida, Executive Director of InnoVero. “The response to our Tasso-based collection system from athletes and anti-doping organizations has been very positive. We are pleased to extend our partnership with Tasso and excited to continue developing innovative solutions together at the forefront of anti-doping technology.”